August 2017 - Volume 27 - Issue 4 - Contributor Index

Alphabetical Search
I
J
Q
U
X
Z
Author:
Alfano, Roberto

Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma

Leon-Ferre, Roberto A.; Kottschade, Lisa A.; Block, Matthew S.; More

Melanoma Research . 27(4):335-341, August 2017.

Author:
Alós, Llucia

Prognostic role of the histological subtype of melanoma on the hands and feet in Caucasians

Carrera, Cristina; Gual, Adrià; Díaz, Alba; More

Melanoma Research . 27(4):315-320, August 2017.

Peptide-pulsed dendritic cell vaccine in combination with carboplatin and paclitaxel chemotherapy for stage IV melanoma

Fukuda, Keitaro; Funakoshi, Takeru; Sakurai, Toshiharu; More

Melanoma Research . 27(4):326-334, August 2017.

Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland

Mangana, Joanna; Cheng, Phil F.; Kaufmann, Corina; More

Melanoma Research . 27(4):358-368, August 2017.

Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience

de Rosa, Francesco; Ridolfi, Laura; Fiammenghi, Laura; More

Melanoma Research . 27(4):351-357, August 2017.

Author:
Arguis, Pedro

Prognostic role of the histological subtype of melanoma on the hands and feet in Caucasians

Carrera, Cristina; Gual, Adrià; Díaz, Alba; More

Melanoma Research . 27(4):315-320, August 2017.

Author:
Baskol, Mevlüt
Author:
Bender, Carolin
Author:
Blasig, Hanna

Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma

Leon-Ferre, Roberto A.; Kottschade, Lisa A.; Block, Matthew S.; More

Melanoma Research . 27(4):335-341, August 2017.

Author:
Braun, Ralph P.

Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland

Mangana, Joanna; Cheng, Phil F.; Kaufmann, Corina; More

Melanoma Research . 27(4):358-368, August 2017.

Author:
Brolli, Claudia

Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience

de Rosa, Francesco; Ridolfi, Laura; Fiammenghi, Laura; More

Melanoma Research . 27(4):351-357, August 2017.

Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience

de Rosa, Francesco; Ridolfi, Laura; Fiammenghi, Laura; More

Melanoma Research . 27(4):351-357, August 2017.

Prognostic role of the histological subtype of melanoma on the hands and feet in Caucasians

Carrera, Cristina; Gual, Adrià; Díaz, Alba; More

Melanoma Research . 27(4):315-320, August 2017.

Author:
Cassan, Serena

Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience

de Rosa, Francesco; Ridolfi, Laura; Fiammenghi, Laura; More

Melanoma Research . 27(4):351-357, August 2017.

Author:
Castel, Teresa

Prognostic role of the histological subtype of melanoma on the hands and feet in Caucasians

Carrera, Cristina; Gual, Adrià; Díaz, Alba; More

Melanoma Research . 27(4):315-320, August 2017.

Author:
Cheng, Phil F.

Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland

Mangana, Joanna; Cheng, Phil F.; Kaufmann, Corina; More

Melanoma Research . 27(4):358-368, August 2017.

Author:
Conill, Carlos

Prognostic role of the histological subtype of melanoma on the hands and feet in Caucasians

Carrera, Cristina; Gual, Adrià; Díaz, Alba; More

Melanoma Research . 27(4):315-320, August 2017.

Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma

Leon-Ferre, Roberto A.; Kottschade, Lisa A.; Block, Matthew S.; More

Melanoma Research . 27(4):335-341, August 2017.

Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience

de Rosa, Francesco; Ridolfi, Laura; Fiammenghi, Laura; More

Melanoma Research . 27(4):351-357, August 2017.

Author:
Deniz, Kemal
Author:
Díaz, Alba

Prognostic role of the histological subtype of melanoma on the hands and feet in Caucasians

Carrera, Cristina; Gual, Adrià; Díaz, Alba; More

Melanoma Research . 27(4):315-320, August 2017.

Author:
Dogan, Ender

Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma

Leon-Ferre, Roberto A.; Kottschade, Lisa A.; Block, Matthew S.; More

Melanoma Research . 27(4):335-341, August 2017.

Author:
Dumezy, Florent

Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland

Mangana, Joanna; Cheng, Phil F.; Kaufmann, Corina; More

Melanoma Research . 27(4):358-368, August 2017.

Author:
Erturk, Kayhan

Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience

de Rosa, Francesco; Ridolfi, Laura; Fiammenghi, Laura; More

Melanoma Research . 27(4):351-357, August 2017.

Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience

de Rosa, Francesco; Ridolfi, Laura; Fiammenghi, Laura; More

Melanoma Research . 27(4):351-357, August 2017.

Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland

Mangana, Joanna; Cheng, Phil F.; Kaufmann, Corina; More

Melanoma Research . 27(4):358-368, August 2017.

Author:
French, Lars E.

Peptide-pulsed dendritic cell vaccine in combination with carboplatin and paclitaxel chemotherapy for stage IV melanoma

Fukuda, Keitaro; Funakoshi, Takeru; Sakurai, Toshiharu; More

Melanoma Research . 27(4):326-334, August 2017.

Author:
Fukuda, Keitaro

Peptide-pulsed dendritic cell vaccine in combination with carboplatin and paclitaxel chemotherapy for stage IV melanoma

Fukuda, Keitaro; Funakoshi, Takeru; Sakurai, Toshiharu; More

Melanoma Research . 27(4):326-334, August 2017.

Peptide-pulsed dendritic cell vaccine in combination with carboplatin and paclitaxel chemotherapy for stage IV melanoma

Fukuda, Keitaro; Funakoshi, Takeru; Sakurai, Toshiharu; More

Melanoma Research . 27(4):326-334, August 2017.

Author:
Gaggadi, Maria

Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience

de Rosa, Francesco; Ridolfi, Laura; Fiammenghi, Laura; More

Melanoma Research . 27(4):351-357, August 2017.

Author:
Gogas, Helen

Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland

Mangana, Joanna; Cheng, Phil F.; Kaufmann, Corina; More

Melanoma Research . 27(4):358-368, August 2017.

Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience

de Rosa, Francesco; Ridolfi, Laura; Fiammenghi, Laura; More

Melanoma Research . 27(4):351-357, August 2017.

Author:
Gual, Adrià

Prognostic role of the histological subtype of melanoma on the hands and feet in Caucasians

Carrera, Cristina; Gual, Adrià; Díaz, Alba; More

Melanoma Research . 27(4):315-320, August 2017.

Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience

de Rosa, Francesco; Ridolfi, Laura; Fiammenghi, Laura; More

Melanoma Research . 27(4):351-357, August 2017.

Author:
Gürsoy, Sebnem
Author:
Gutzmer, Ralf
Author:
Held, Ulrike

Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland

Mangana, Joanna; Cheng, Phil F.; Kaufmann, Corina; More

Melanoma Research . 27(4):358-368, August 2017.

Author:
Kassi, Eva

Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland

Mangana, Joanna; Cheng, Phil F.; Kaufmann, Corina; More

Melanoma Research . 27(4):358-368, August 2017.

Peptide-pulsed dendritic cell vaccine in combination with carboplatin and paclitaxel chemotherapy for stage IV melanoma

Fukuda, Keitaro; Funakoshi, Takeru; Sakurai, Toshiharu; More

Melanoma Research . 27(4):326-334, August 2017.

Author:
Koop, Anika

Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma

Leon-Ferre, Roberto A.; Kottschade, Lisa A.; Block, Matthew S.; More

Melanoma Research . 27(4):335-341, August 2017.

Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma

Leon-Ferre, Roberto A.; Kottschade, Lisa A.; Block, Matthew S.; More

Melanoma Research . 27(4):335-341, August 2017.

Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland

Mangana, Joanna; Cheng, Phil F.; Kaufmann, Corina; More

Melanoma Research . 27(4):358-368, August 2017.

Author:
Lin, Hui-Min
Author:
Lin, Yan
Author:
Longo, Caterina
Author:
Lowe, Val J.

Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma

Leon-Ferre, Roberto A.; Kottschade, Lisa A.; Block, Matthew S.; More

Melanoma Research . 27(4):335-341, August 2017.

Author:
Malvehy, Josep

Prognostic role of the histological subtype of melanoma on the hands and feet in Caucasians

Carrera, Cristina; Gual, Adrià; Díaz, Alba; More

Melanoma Research . 27(4):315-320, August 2017.

Author:
Mangana, Joanna

Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland

Mangana, Joanna; Cheng, Phil F.; Kaufmann, Corina; More

Melanoma Research . 27(4):358-368, August 2017.

Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma

Leon-Ferre, Roberto A.; Kottschade, Lisa A.; Block, Matthew S.; More

Melanoma Research . 27(4):335-341, August 2017.

Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma

Leon-Ferre, Roberto A.; Kottschade, Lisa A.; Block, Matthew S.; More

Melanoma Research . 27(4):335-341, August 2017.

Author:
Mendt, Mayela

Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland

Mangana, Joanna; Cheng, Phil F.; Kaufmann, Corina; More

Melanoma Research . 27(4):358-368, August 2017.

Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience

de Rosa, Francesco; Ridolfi, Laura; Fiammenghi, Laura; More

Melanoma Research . 27(4):351-357, August 2017.

Author:
Mori, Mariko

Peptide-pulsed dendritic cell vaccine in combination with carboplatin and paclitaxel chemotherapy for stage IV melanoma

Fukuda, Keitaro; Funakoshi, Takeru; Sakurai, Toshiharu; More

Melanoma Research . 27(4):326-334, August 2017.

Author:
Murer, Carla

Peptide-pulsed dendritic cell vaccine in combination with carboplatin and paclitaxel chemotherapy for stage IV melanoma

Fukuda, Keitaro; Funakoshi, Takeru; Sakurai, Toshiharu; More

Melanoma Research . 27(4):326-334, August 2017.

Author:
Nanni, Oriana

Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience

de Rosa, Francesco; Ridolfi, Laura; Fiammenghi, Laura; More

Melanoma Research . 27(4):351-357, August 2017.

Author:
Nicolis, Morena

Prognostic role of the histological subtype of melanoma on the hands and feet in Caucasians

Carrera, Cristina; Gual, Adrià; Díaz, Alba; More

Melanoma Research . 27(4):315-320, August 2017.

1 2 Next